Mahboobeh Yeganeh-Hajahmadi

Dr. Mahboobeh Yeganeh-Hajahmadi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2015 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
HNHamid Najafipour
Hamid Najafipour
AVAbedin Vakili
Abedin Vakili
BSBeydolah Shahouzehi
Beydolah Shahouzehi
AHAva Soltani Hekmat
Ava Soltani Hekmat
YMYaser Masoomi
Yaser Masoomi
SESaeed Esmaeli-Mahani
Saeed Esmaeli-Mahani

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
MSMitra Shadkam-Farrokhi
Mitra Shadkam-Farrokhi
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
HNHamid Najafipour
Hamid Najafipour
ZAZeinab Ansari-Asl
Zeinab Ansari-Asl
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
Introduction. The biocompatibility and potential application of graphene‐based nanomaterials in biomedicine have been documented. The effects of polyethylene glycol‐graphene quantum dots (GQDs‐PEG) on cardiac function in rats with myocardial infarction (MI) were examined. Methods. Wistar rats were randomly assigned to two main groups, each consisting of sham‐Veh., MI‐Veh., and MI+GQDs‐PEG at doses of 5, 10, and 20 mg/kg. MI was induced by the closure of the left anterior descending (LAD) coronary artery. After MI, GQDs‐PEG were injected at different doses IP every other day for two weeks. In the end, hemodynamic and heart contractility indices were assessed. The levels of myocardial MDA (malondialdehyde), SOD (superoxide dismutase), GPX (glutathione peroxidase), and TAC (total antioxidant capacity) were measured by the ELISA method. The serum ALP, ALT, AST, creatinine, and urea levels were measured using the photometric method. The infarct size was assessed by TTC staining. Results. GQDs‐PEG decreased the infarct size at doses of 10 and 20 mg/kg and recovered the MI‐induced reductions of +dp/dt max and ‐dp/dt max in the study groups. GQDs‐PEG normalized systolic blood pressure and left ventricular systolic pressure reduction at the dose of 20 mg/kg in the MI group. Heart SOD, GPX, and TAC increased in the GQDs‐PEG 10 and 20 groups. Almost no signs of toxic effects due to GQDs‐PEG administration were observed on the liver and kidneys. Conclusions. The results provided clear evidence that GQDs‐PEG improve cardiac performance and hemodynamic parameters in rats with MI by reducing oxidative stress. GQDs‐PEG is proposed as a therapeutic target for the treatment of MI.

2 October 2024 in npj Aging
Verified
Journal Article
Open access
PDF file
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
SJSiyavash Joukar
Siyavash Joukar
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
The prevalence of sleep disorders has been reported from 1.6% to 56.0%, worldwide. Sleep deprivation causes cardiovascular diseases (CVDs) including atherosclerosis, vascular aging, hypertension, heart dysfunction, reduced heart rate variability, and cardiac arrhythmia. Reduced tissue oxygen causes various CVDs by activating pro-inflammatory factors and increasing oxidative stress. Sleep disorders are more important and prevalent in older people and cause more severe cardiovascular complications. On the other hand, the reduction of Klotho level, an age-dependent protein whose expression decreases with age, is associated with age-related diseases. Sirtuins, class III histone deacetylases, also are among the essential factors in postponing cellular aging and increasing the lifespan of organisms, and they do this by regulating different pathways in the cell. Sirtuins and Klotho play an important role in the pathophysiology of CVDS and both have anti-oxidative stress and anti-inflammatory activity. Studies have shown that the levels of Klotho and sirtuins are altered in sleep disorders. In this article, alterations of Klotho and sirtuins in sleep disorders and in the development of sleep-related CVDs were reviewed and the possible signaling pathways were discussed. The inclusion criteria were studies with keywords of different types of sleep disorders and CVDs, klotho, SIRT1-7, and sirtuins in PubMed, Scopus, Embase، Science Direct، Web of Sciences and Google Scholar by the end of 2023. The studies revealed there is a bidirectional relationship between sleep disorders and the serum and tissue levels of Klotho and sirtuins and sleep related-CVDs.

6 October 2023 in Experimental Gerontology
Verified
Journal Article
Open access
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
YMYasamin Moosavi-Saeed
Yasamin Moosavi-Saeed
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
In this article, we review the articles that have reported the interaction between Klotho and sirtuins. Sirtuins are a family of histone deacetylase enzymes that are considered to be the main regulators of biological processes. This family is one of the essential factors for postponing aging and increasing the life span of organisms. Sirtuins play a role in regulating the function of various cellular processes such as cellular metabolism, oxidative stress, apoptosis, and inflammation. It has also been shown that various diseases are related to these enzymes. Klotho is an anti-aging protein that exists as a membrane protein as well as a soluble circulating form. The membrane type of this protein acts as a co-receptor of the FGF endocrine family. It has been shown that the Klotho gene is related to age-related diseases, including osteoporosis, coronary artery, brain diseases, diabetes, etc. At the same time, it is difficult to separate the actions of Klotho and endocrine FGFs. Several studies have shown that Klotho and sirtuins interact with each other at different regulatory levels. However, it is necessary to carry out more in-vivo investigations to create new windows towards the treatment or prevention of various diseases.

18 August 2023 in Current Molecular Pharmacology
Verified
Journal Article
Open access
PDF file
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
YMYasamin Moosavi-Saeed
Yasamin Moosavi-Saeed
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
Apelin and its receptor are expressed in many tissues and play an important role in maintaining the homeostasis of the cardiovascular system and body fluids. Also, the association of this system with many diseases, such as diabetes, hypertension, obesity, cancer, diabetic retinopathy, etc., has been determined. This system is considered a therapeutic goal in many mentioned diseases. G protein-coupled receptors (GPCRs) have the ability to form oligomers and dimers with themselves and other receptors. The formation of these oligomers is associated with a change in the signaling pathways of the receptors. Research on the oligo and dimers of these receptors can revolutionize the principles of pharmacology. The apelin receptor (APJ) is also a GPCR and has been shown to have the ability to form dimers and oligomers. This article discusses the dimerization and oligomerization of this receptor with its own receptor and other receptors, as well as the signaling pathways.

21 June 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
ZKZeinab Kordestani
Zeinab Kordestani
YMYasmin Moosavi-Saeed
Yasmin Moosavi-Saeed
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
Cardiac ischemic preconditioning (Pre) reduces cardiac ischemia–reperfusion injury (IRI) by stimulating opioid receptors. Chronic use of opioids can alter the signaling pathways. We investigated the effects of chronic methadone use on IRI and Pre. The experiments were performed on isolated hearts of male Wistar rats in four groups: IRI, Methadone + IRI (M-IRI), Pre + IRI (Pre-IRI), Methadone + Pre + IRI (M-Pre-IRI). The infarct size (IS) in the Pre-IRI group was smaller than the IRI group (26.8% vs. 47.8%, P < 0.05). In the M-IRI and M-Pre-IRI groups, the infarct size was similar to the IRI group. Akt (Ak strain transforming) phosphorylation in the Pre-IRI, M-IRI, and M-Pre-IRI groups was significantly higher than in the IRI group (0.56 ± 0.15, 0.63 ± 0.20, and 0.93 ± 0.18 vs 0.28 ± 0.17 respectively). STAT3 (signal transducer and activator of transcription 3) phosphorylation in the Pre-IRI and M-Pre-IRI groups (1.38 ± 0.14 and 1.46 ± 0.33) was significantly higher than the IRI and M-IRI groups (0.99 ± 0.1 and 0.98 ± 0.2). Thus, chronic use of methadone not only has no protective effect against IRI but also destroys the protective effects of ischemic preconditioning. This may be due to the hyperactivation of Akt and changes in signaling pathways.